Bridgepoint-backed Diaverum, a Sweden-based renal care provider, is preparing to launch an initial public offering in November, according to press reports.
Bridgepoint-backed Diaverum, a Sweden-based renal care provider, is preparing to launch an initial public offering in November, according to press reports.